期刊文献+

冠心病介入治疗前后心功能与胱抑素C的对比观察 被引量:7

Comparison of cardiac function and concentration of cystatin C before and after interventional therapy in the patients with coronary heart disease
下载PDF
导出
摘要 目的探讨冠心病患者介入治疗前后心功能与血清胱抑素C(CysC)的变化。方法入选我院住院200例冠心病患者,应用超声心动图测量其介入前及介入后6个月的左心室室壁运动积分指数(WMSI)、左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)及左心室射血分数(LVEF);检验介入前及介入后6个月CysC浓度变化情况。结果介入治疗后WMSI及LVEF较术前明显改善,LVEDD及LVESD均较术前缩小,CysC较术前降低(P<0.01)。结论介入治疗可以改善冠心病患者心功能,降低CysC浓度。CysC可以作为心衰患者独立危险因子。 Objective To discuss the change of cardiac function and concentration of CysC from before and after imerventional therapy in patients with coronary artery disease. Methods In 200 hospital patients with coronary artery disease in our hospital, the WMSI, LVEF, LVEDD and LVESD before and after interventional therapy were measured by eehocardiography and the concentration of CysC in blood before and after interventional therapy were determined. Their results were compared. Results WMSI and LVEF after interventional therapy were significantly better than before interventional therapy. LVEDD and LEVSD after interventional therapy were smaller than before interventional therapy. The concentration of CysC after interventional therapy was lower than before interventional therapy (P 〈 0. 05 ). Conclusion Interventional therapy can improve cardiac function of patients with coronary artery disease, and cut down the concentration of CysC. The concentration of CysC was a univariate predictor of patients with heart failure.
出处 《中国临床新医学》 2010年第1期38-40,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 冠心病 介入治疗 心功能 胱抑素C Coronary heart disease Interventional therapy Cardiac function Cystatin C
  • 相关文献

同被引文献60

  • 1J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 2陈奇奥,徐永成,孙敏血清胱抑素c在冠心病中的临床价值[J].中外健康文摘,2010,7(23):148-150.
  • 3Libby P. Inflammation in atherosclerosis[ J ]. Artefioscler Thromb Vascbiol, 2012, 32(9): 2045-2051.
  • 4Kashiwagi M, Imanishi T, Tsujioka I-I, et al. Association of mono- cyte subsets with vulnerability charactetistics of coronary plaques as assessed by 64 - slice multidetidetector computed tomography in patients with stable angina pectoris [ J ]. Atherosclerosis, 2010, 212(1): 171-176.
  • 5Koc M, Batur MK, Karaarslan O, et al. Clinical utility of serum cystatin C in predicting coronary artery disease [ J ]. Cardio] J, 2010, 17(4) : 374 -380.
  • 6Taglier N, Koenig W, Kaski JC. Cystain Cand cardiovascular risk [J]. Ann Biol Clin(Paris), 2010, 68(5) : 517 -529.
  • 7Kiyosue A, Hirata Y, Ando J, et al. Plasma cystatin C concentra- tion reflects the severity of coronary artery disease in patients with- out chronic kidney disease[J]. Circ J, 2010, 74 (11) : 2441 - 2447.
  • 8Bayturan O, Tuzeu EM, Uno K, eta[. Comparison of rates of pro- gression of coronary atherosclerosis in patients with diabetes melli- tus versus those with the metabolic syndrome[ J]. Am J Cardiol, 2010, 105(12): 1735-1739.
  • 9Gran~r M, Tikkanen E, Rimpila O, et al. Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjectswith chest pain [ J ]. Ann Med, 2013, 45 (4) : 322 - 327.
  • 10Mori T, Town T, Tan J, et al. Modulation of astrocytic activation by arundic acid ( ONO - 2506 ) mitigates detrimental effects of the apo lipoprotein E4 isofbrm after permanent focal isehemia in apo lipoprotein E knock inmice[ J~. ~ Cereh Blood FlowMetab, 2005, 25(6) : 748 -762.

引证文献7

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部